6월 23, 2021 Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Biosimulation Software for Evaluating Regulatory Submissions
5월 20, 2021 Certara to Participate in the William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference
5월 13, 2021 Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies